Sellbyville, Delaware, March 15, 2019 (GLOBE NEWSWIRE) --

Australian pet cancer therapeutics market is forecast to grow at over 12.6% CAGR in given timeframe. High growth is due to growing pet-keeping trend, availability of innovative pet care medicines and increasing disposable income of pet owners.

Global Pet Cancer Therapeutics Market is expected to surpass USD 359.4 million by 2025; according to a new research report by Global Market Insights, Inc. Growing pet adoption rate coupled with increasing disposable income of pet owners will drive pet cancer therapeutics industry growth. Strong and robust drug pipeline for treatment of pet cancer will stimulate business growth over the forecast years.

Rising number of pet dogs suffering from cancer will spur orthopedic implants and devices demand. According to American Veterinary Cancer Society, nearly 50% of dogs over the age of 10 have cancer and die of it. The need to control cancer in pets and pet owners will to save their pet from cancer is a major reason behind development in cancer therapeutics.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/2017

However, high cost of pet cancer drugs along with rising instances of adverse drug events should hamper industry growth over the forecast years. Lack of awareness regarding pet diseases among the pet owners will impede industry expansion.

Chemotherapy has been the mainstream medication for pet cancers till recent times. However, immunological vaccines entered the market and are gaining significant market share. With number of chemotherapy drugs in pipeline, the industry should witness considerable growth over the coming years.

Browse key industry insights spread across 120 pages with 141 market data tables & 8 figures & charts from the report, “Pet Cancer Therapeutics Market By Medicine Type (Chemotherapy Drugs, Vaccines), By Species (Dogs, Cats), By Cancer Type (Lymphoma, Mast Cell Cancer, Melanoma, Mammary and Squamous Cell Cancer), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, Japan, China, India, Australia, Brazil, Mexico), Application Growth Potential, Price Trends, Competitive Market Share & Forecast, 2019 - 2025” in detail along with the table of contents:

https://www.gminsights.com/industry-analysis/pet-cancer-therapeutics-market

Dogs are more prone to develop cancer than cats and the healthy pipeline will drive segment growth over the forecast years. However, introduction of specialized cat cancer medicines will stimulate the cat cancer therapeutics market growth.

Pet healthcare companies are focusing on development of drugs for mast cell cancer and melanoma among other cancer types. This trend will witness change as medicines to treat lymphoma and mammary cell cancer are in the pipeline. Innovative medicines for treatment of multiple cancer tumors is anticipated to accelerate business growth.

U.S. pet cancer therapeutics market is expected to reach USD 281.2 million by 2025. Presence of large number of pet drug manufacturing companies, quick adoption of innovative pet care medicines and increasing disposable income of pet owners will boost industry growth.

Some of the leading industry players include Zoetis, Merial, Aratana Therapeutics, AB Science, Vetivax, Oasmia Pharmaceutical, VetDC, Regeneus, CanFel Therapeutics, Karyopharms Verdinexor. The most commonly adopted business strategies by industry participants includes new product launches, regional expansion and mergers and acquisition.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/2017

Browse Related Reports:

Global Animal Vaccines Market By Animal Types (Farm Animal Vaccines {Poultry Vaccines, Cattle Vaccines, Swine Vaccines, Equine Vaccines, Aquaculture Vaccines}, Companion Animal Vaccines {Dog Vaccines, Cat Vaccines}), By Technology (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines), By Infections (Bacterial Vaccines, Viral Vaccines, Parasitic Vaccines, Fungal Vaccines), By Route of Administration (Injection Vaccines, Oral Vaccines, Immersion/Spray Vaccines) Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2019 – 2025

https://www.gminsights.com/industry-analysis/animal-vaccines-market

Animal Healthcare Market By Pharmaceuticals (Ectoparasiticides, Endoparasiticides, Anti-inflammatories, Anti-infectives), By Vaccines (Poultry, Cattle, Swine, Equine, Dogs, Cats, Horses), By Medicated Feed Additives( Antibiotics, Vitamins, Amino acids, Enzymes, Antioxidants, Prebiotics and Probiotics, Minerals), By Animal Type ( Farm Animal And Companion Animal), Regional Outlook, Technology Development, Competitive Landscape & Forecast, 2018 – 2024       

https://www.gminsights.com/industry-analysis/animal-healthcare-market

About Global Market Insights

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: https://www.gminsights.com
Blog: http://healthcareopportunity.org/